APS
APS Virtual Poster Showcase · 2020
Concerns with and Support for Immunotherapy for Substance Use Disorder
- Kathryn Hodges
Muhlenberg College - Meray Faragalla
Muhlenberg College - Brittany Bashore
Muhlenberg College - David Woodbury
Muhlenberg College - Jeffrey Rudski
Muhlenberg College
Abstract
Immunotherapy (IT) treatments are being developed for Substance Use Disorder (SUD). Participants believed such treatments are likely to be effective, but were concerned with diminished autonomy, increased overdose risk, and decreased efficacy of related medications (particularly for children). Support increased when considering IT for people with histories of SUD.
Addiction